Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

Share Price is delayed by 15 minutes
Get Live Data
75.60    -1.70 (-2.20%)
Bid:
75.20
Ask:
75.70
Spread: 0.50 (0.665%)
Market Cap: £524.87m
DATA Live PriceLast checked at - London Stock Exchange

Intraday GlobalData Share Chart

Trading Update

25 Nov 2020 07:00

RNS Number : 3967G
GlobalData PLC
25 November 2020
 

25 November 2020

GlobalData Plc

Trading Update

Continued strong performance, full year outlook in-line with expectations

GlobalData PLC, the global provider of data, analytics, and insights, provides the following trading update for the 10 months to 31 October 2020 (the "period").

 

Key highlights:

 

· Revenue excluding events grew by +5% compared to the 10 months ended 31 October 2019 (the "previous period"), driven by 7% growth in subscription revenue. Overall Group revenue is flat versus the previous period.

 

· Forward contracted revenue increase of +8% versus 31 October 2019 (+ 9% excluding events)

 

· Adjusted EBITDA is 12% up for the period, with a margin improvement of 3 percentage points to 32% versus the previous period.

 

· Strong cash flow from operations, which has grown 8% versus the previous period.

 

· Net debt has risen from £41.2m at June 2020 to £51.4m, with strong operating cash flow offset by dividend payment and purchase of IT equipment.

 

The Group has continued to perform well despite the challenging macro environment, with subscription revenue growth of 7% in line with our recent half-year results. We have started to see momentum in sales order growth at the end of Q3 and the start of Q4 2020, which is encouraging, and will be a key driver of revenues in 2021. Despite the headwind impact of COVID-19 on our events revenue, full year total Group revenues are expected to be flat.

 

In line with our normal renewal cycle we still have work to do in November and December to secure renewal business, but the momentum we are currently seeing gives us confidence that we will deliver a strong finish to the year and start the new financial year with a significant percentage of our annual revenues already secure.

 

Full Year Adjusted EBITDA for the current financial year is expected to be in line with the Board's expectations.

 

The financial results for the year ending 31 December 2020 will be announced on 1 March 2021 and will be available on our website www.globaldata.com

 

 

ENQUIRIES:

GlobalData Plc

Mike Danson, Chief Executive Officer 0207 936 6400

Graham Lilley, Chief Financial Officer

Brokers

Bill Hutchings/ Mose Adigun - J.P. Morgan Cazenove (Nomad and joint broker) 0207 742 4000

Sam Barnett - HSBC (Joint broker) 0207 991 8888

Erik Anderson/ Alina Vaskina - Panmure Gordon (Joint Broker) 020 7886 2500

Hudson Sandler

Nick Lyon 0207 796 4133

 

Adjusted EBITDA - Earnings before interest, tax, depreciation, amortisation adjusted for costs associated with acquisitions, restructuring of the Group, share based payments, impairment, unrealised operating exchange rate movements and impact of foreign exchange contracts.

Forward contracted revenue - Deferred revenue plus contracted revenue for the next 2021 months with a future billing date.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPGRGGUPUPPC
Date   Source Headline
28th Jun 202212:45 pmRNSAnnual Report FY2021
26th Apr 202212:32 pmRNSResults of AGM
4th Apr 20221:14 pmRNSNotice of AGM
28th Feb 20227:00 amRNSFinal Year Results
24th Feb 20227:00 amRNSHolding(s) in Company
14th Jan 20224:43 pmRNSPDMR Notification
10th Jan 20227:00 amRNSUpdate on FY21 performance and Capital Markets Day
15th Dec 20217:00 amRNSAcquisition of Automotive and Agribusiness Assets
9th Sep 20217:00 amRNSAcquisition of Life Sciences business
28th Jul 20219:09 amRNSPDMR Notification
26th Jul 20217:00 amRNSUnaudited interim report
2nd Jul 202112:27 pmRNSInterim Accounts
24th Jun 202110:37 amRNSBoard Change
1st Jun 20214:26 pmRNSPDMR Dealing
30th Apr 20217:00 amRNSBoard Change
20th Apr 202110:56 amRNSResults of AGM
26th Mar 20217:00 amRNSNotice of AGM and the proposed appointment of NED
26th Mar 20217:00 amRNSInterim Accounts
15th Mar 20217:00 amRNSAnnual Report
1st Mar 20217:01 amRNSBoard Changes
1st Mar 20217:00 amRNSFinal Results For The Year Ended 31 December 2020
12th Feb 20214:12 pmRNSHolding(s) in Company
18th Jan 20219:17 amRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSBoard Changes
21st Dec 20209:49 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSAppointment of Nomad and Broker
25th Nov 20207:00 amRNSTrading Update
9th Oct 20203:47 pmRNSTransfer of Shares out of Treasury
1st Sep 202012:16 pmRNSHolding(s) in Company
21st Aug 20208:55 amRNSAppointment of Joint Corporate Broker
27th Jul 20207:00 amRNSUnaudited Interim Report
21st May 20204:10 pmRNSEmployee Share Options and PDMR Dealing
19th May 20201:06 pmRNSIncreased Banking Facilities
21st Apr 202011:05 amRNSResults of AGM
21st Apr 20207:00 amRNSCOVID-19 Update, Dividend Deferral and AGM
27th Mar 202011:55 amRNSNotice of AGM
3rd Mar 20207:45 amRNSAnnual Report and Accounts
24th Feb 20207:00 amRNSFinal Results For The Year Ended 31 December 2019
16th Jan 20207:00 amRNSUpdate on Directorate Change
30th Oct 201910:59 amRNSHolding(s) in Company
3rd Oct 20197:00 amRNSDirectorate Change
29th Jul 20197:00 amRNSUnaudited Interim Report
19th Jul 20197:00 amRNSNotice of Results
23rd May 20197:00 amRNSNotice of Capital Markets Day
26th Apr 201912:57 pmRNSDirector/PDMR Dealings
23rd Apr 20194:20 pmRNSResults of AGM
28th Mar 20197:00 amRNSAnnual Report and Accounts and Notice of AGM
11th Mar 201911:41 amRNSPDMR Dealing
25th Feb 20197:00 amRNSFinal Results For The Year Ended 31 December 2018
17th Oct 20182:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.